Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | Y018398 | IM / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | X000532 | IM / RA |
It was noted when charting the Varivax that the vaccine given was expired as of 1/4/25. Contacted Merck to inquire about potency and was told that they have in house data that supports the potency of the vaccine and they do not give recommendations on whether or not dose needs to be repeated. NP states that she will have titers drawn in a few months to see if he has immunity. patient notified and voiced understanding. Incident report filled out.